This is an accordion element with a series of buttons that open and close related content panels.
The Wisconsin HN SPORE Team
HNC SPORE Research Projects
Welcome to the Wisconsin Head & Neck Cancer Specialized Program of Research Excellence!
The University of Wisconsin Department of Human Oncology and the UW Carbone Cancer Center, under the direction of Principal Investigator Paul Harari, were awarded Wisconsin’s first NIH-funded Specialized Program of Research Excellence (SPORE) in August 2016.
The Wisconsin SPORE focuses on Head and Neck Cancer translational research, which means that the goals of each SPORE research project must link laboratory research (bench) to the clinic setting (bedside) and ultimately aim to improve overall outcome for patients with Head and Neck Cancer. The Wisconsin Head and Neck SPORE comprises four main translational research projects, three supporting cores and two pilot funding programs.
The UW HN SPORE team recently hosted its third annual retreat and external advisory board (EAB) meeting. During this one-and-a-half-day event, team members highlighted the progress of SPORE projects and core support programs while soliciting feedback from the EAB as the team begins to focus on renewal themes for this five-year NIH grant.
Federal Funding Opportunities
The NCI has issued four new RFAs for FY19 as part of the Immuno-Oncology Translational Network that might be of interest to the SPORE community. Two are in immunoprevention, one is in immune-engineering, and the final RFA is a reissuance of the immunotherapy (non-pediatric) funding opportunity announcement that has been previously awarded.
RFA-CA-19-012: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed)
RFA-CA-19-013: Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
RFA-CA-19-014: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
RFA-CA-19-015: Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
Funding opportunities for HNSCC research supported by NIDCR
PAR-18-530 “Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment” R01
PAR-18-009 “Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems R01
PA-17-459 “Biology of Lung, and Head and Neck Preneoplasias” R01
PA-17-460 “Biology of Lung, and Head and Neck Preneoplasias” R21
PA-17-239 “Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes” R01
PA-17-243 “Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes” R21